Clinical trial
Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver…
NCT00004136 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00004136 |
|---|---|
| Title | Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer |
| Official title | A Phase II Study of Radiofrequency Ablation of Unresectable Liver Tumors |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Cancer, Metastatic Cancer |
| Intervention type | Procedure |
| Interventions | Radiofrequency Ablation |
| Enrollment | 59 |
| Start date | Mar 9, 1998 |
| Primary completion | Jan 25, 2006 |
| Completion | Jan 25, 2006 |
| First posted | Aug 20, 2004 |
| Last update posted | Nov 6, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: